Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Triptorelin Acetate Utilization for the Early Diagnosis of Central Precocious Puberty (CPP) in Girls.

NCT01278290 is registered in ClinicalTrials.gov with Hospital de Niños R. Gutierrez de Buenos Aires as lead sponsor.

NCT NCT01278290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01278290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Triptorelin Acetate Utilization for the Early Diagnosis of Central Precocious Puberty (CPP) in Girls.
Lead sponsor
Hospital de Niños R. Gutierrez de Buenos Aires
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2009
Completion date
June 30, 2011
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central precocious puberty, sexual precocity